{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022751","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2025-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.677682+00:00","generated_at":"2026-05-17T16:12:02.577704+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NanoVibronix effects 1-for-10 reverse stock split effective Aug 11, 2025","bullets":["Reverse stock split reduces outstanding shares from 7,968,868 to ~796,887.","Effective 4:05 p.m. ET on Aug 11, 2025; split-adjusted trading begins Aug 12, 2025.","No fractional shares issued; any fractional shares rounded up to whole number.","Adjustments made to equity awards, warrants, and convertible securities proportionally.","New CUSIP 63008J884; trading symbol remains NAOV on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022751","json":"https://secwatch.observer/filing/0001641172-25-022751.json","markdown":"https://secwatch.observer/filing/0001641172-25-022751.md","text":"https://secwatch.observer/filing/0001641172-25-022751.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225022751/0001641172-25-022751-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225022751/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T16:12:02.577704+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7e88510bea76e5075c397cb7291439f2ff6d7e13","claim":"ENvue Medical, Inc.: 1-for-10 reverse stock split of common stock (effective 2025-08-11).","evidence_excerpt":"filed a Certificate of Amendment (the “ Certificate of Amendment ”) to the Company’s Amended and Restated Certificate of Incorporation (as amended, the “ Certificate of Incorporation ”) with the Secretary of State of Delaware to effect a 1-for-10 reverse stock split","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225022751/0001641172-25-022751-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-08-11"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}